title: Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y.
abstract: Tumor-bearing rats exhibited significant decreases in 1- to 4-h intake of rat chow following the intrahypothalamic injection of 2 micrograms neuropeptide Y (NPY). This refractory feeding response was present prior to the onset of anorexia and became more severe as anorexia worsened. The constant infusion of NPY (125 ng/h) into the perifornical hypothalamus of TB and control rats elicited increased feeding for only 2 days. Because chromatography revealed minipump NPY to be intact after 10 infusion days, downregulation of NPY receptors may have occurred. Daily injection of increasing doses of NPY stimulated ad lib feeding in non-TB rats, while having no effect on TB rats. Desensitization to NPY-induced feeding following daily injections of the peptide was suggested by the loss of feeding response to a dose (500 ng) of NPY that increased food intake prior to the daily NPY treatments. These results suggest that hypothalamic NPY feeding systems are refractory in TB rats, even before they exhibit anorexia. In addition, a rapid loss of the feeding response occurred in rats with constant infusion of NPY into hypothalamic tissue or with daily intrahypothalamic injections of the peptide, suggesting possible NPY receptor-mediated alterations. Therefore, control of obesity or anorexia through NPY feeding mechanisms may prove difficult due to rapid compensatory receptor changes.
authors.affiliation: Veterans Affairs Medical Center, Cincinnati, OH, USA.
authors.forename: W T
authors.initials: WT
authors.lastname: Chance
authors.forename: A
authors.initials: A
authors.lastname: Balasubramaniam
authors.forename: H
authors.initials: H
authors.lastname: Thompson
authors.forename: B
authors.initials: B
authors.lastname: Mohapatra
authors.forename: J
authors.initials: J
authors.lastname: Ramo
authors.forename: J E
authors.initials: JE
authors.lastname: Fischer
mesh_terms: D000818:Animals; D000855:Anorexia / Q000188:drug therapy / Q000209:etiology; D019167:Appetite Stimulants / Q000008:administration & dosage* / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology; D005247:Feeding Behavior / Q000187:drug effects* / Q000502:physiology; D007031:Hypothalamus / Q000187:drug effects / Q000502:physiology*; D015918:Infusion Pumps, Implantable; D007267:Injections; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D009478:Neuropeptide Y / Q000008:administration & dosage* / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D012513:Sarcoma, Experimental / Q000139:chemically induced; D013997:Time Factors
chemical_list: D019167:Appetite Stimulants; D002273:Carcinogens; D009478:Neuropeptide Y; D008748:Methylcholanthrene